1. Metabolic characteristics of 13‐cis‐retinoic acid (isotretinoin) and anti‐tumour activity of the 13‐cis‐retinoic acid metabolite 4‐oxo‐13‐cis‐retinoic acid in neuroblastoma. (December 2014) Authors: Sonawane, Poonam; Cho, Hwang Eui; Tagde, Ashujit; Verlekar, Dattesh; Yu, Alice L; Reynolds, C Patrick; Kang, Min H Journal: British journal of pharmacology Issue: Volume 171:Number 23(2014:Dec.) Page Start: 5330 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. MUC1-C promotes the suppressive immune microenvironment in non-small cell lung cancer. (2nd September 2017) Authors: Bouillez, Audrey; Adeegbe, Dennis; Jin, Caining; Hu, Xiufeng; Tagde, Ashujit; Alam, Maroof; Rajabi, Hasan; Wong, Kwok-Kin; Kufe, Donald Journal: Oncoimmunology Issue: Volume 6:Number 9(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. MUC1‐C drives myeloid leukaemogenesis and resistance to treatment by a survivin‐mediated mechanism. Issue 8 (15th May 2018) Authors: Stroopinsky, Dina; Rajabi, Hasan; Nahas, Myrna; Rosenblatt, Jacalyn; Rahimian, Maryam; Pyzer, Athalia; Tagde, Ashujit; Kharbanda, Akriti; Jain, Salvia; Kufe, Turner; Leaf, Rebecca K.; Anastasiadou, Eleni; Bar‐Natan, Michal; Orr, Shira; Coll, Maxwell D.; Palmer, Kristen; Ephraim, Adam; Cole, Leand... Journal: Journal of cellular and molecular medicine Issue: Volume 22:Issue 8(2018) Page Start: 3887 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. MUC1‐C is a target in lenalidomide resistant multiple myeloma. (23rd June 2017) Authors: Yin, Li; Tagde, Ashujit; Gali, Reddy; Tai, Yu‐Tzu; Hideshima, Teru; Anderson, Kenneth; Avigan, David; Kufe, Donald Journal: British journal of haematology Issue: Volume 178:Number 6(2017) Page Start: 914 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗